[HTML] nature.com

[HTML][HTML] The Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer

C Blanc, A Moktefi, A Jolly, P De La Grange… - British Journal of …, 2023 - nature.com
Background Neuroendocrine prostate cancer (NEPC) is a multi-resistant variant of prostate
cancer (PCa) that has become a major challenge in clinics. Understanding the …
被引用次数：7 相关文章
[HTML] nih.gov

[HTML][HTML] The Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer

C Blanc, A Moktefi, A Jolly, P de la Grange… - British Journal of …, 2023 - ncbi.nlm.nih.gov
Background Neuroendocrine prostate cancer (NEPC) is a multi-resistant variant of prostate
cancer (PCa) that has become a major challenge in clinics. Understanding the …

The Neuropilin-1/PKC Axis Promotes Neuroendocrine Differentiation and Drug Resistance of Prostate Cancer

C Blanc, A Moktefi, A Jolly, P De La Grange… - British Journal of …, 2023 - hal.science
Background: Neuroendocrine prostate cancer (NEPC) is a multi-resistant variant of prostate
cancer (PCa) that has become a major challenge in the clinics. Understanding …

The Neuropilin-1/PKC Axis Promotes Neuroendocrine Differentiation and Drug Resistance of Prostate Cancer

C Blanc, A Moktefi, A Jolly, P De La Grange… - British Journal of …, 2023 - inria.hal.science
Background: Neuroendocrine prostate cancer (NEPC) is a multi-resistant variant of prostate
cancer (PCa) that has become a major challenge in the clinics. Understanding …

The Neuropilin-1/PKC Axis Promotes Neuroendocrine Differentiation and Drug Resistance of Prostate Cancer

C Blanc, A Moktefi, A Jolly, P De La Grange… - British Journal of …, 2023 - cea.hal.science
Background: Neuroendocrine prostate cancer (NEPC) is a multi-resistant variant of prostate
cancer (PCa) that has become a major challenge in the clinics. Understanding …

The Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer

C Blanc, A Moktefi, A Jolly… - British journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Neuroendocrine prostate cancer (NEPC) is a multi-resistant variant of prostate
cancer (PCa) that has become a major challenge in clinics. Understanding the …

The Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer.

C Blanc, A Moktefi, A Jolly, P de la Grange… - British Journal of …, 2022 - europepmc.org
Background Neuroendocrine prostate cancer (NEPC) is a multi-resistant variant of prostate
cancer (PCa) that has become a major challenge in clinics. Understanding the …

The Neuropilin-1/PKC Axis Promotes Neuroendocrine Differentiation and Drug Resistance of Prostate Cancer

C Blanc, A Moktefi, A Jolly, P De La Grange… - British Journal of …, 2023 - hal.u-pec.fr
Background: Neuroendocrine prostate cancer (NEPC) is a multi-resistant variant of prostate
cancer (PCa) that has become a major challenge in the clinics. Understanding …

The Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer.

C Blanc, A Moktefi, A Jolly, P de la Grange… - British Journal of …, 2022 - europepmc.org
Neuroendocrine prostate cancer (NEPC) is a multi-resistant variant of prostate cancer (PCa)
that has become a major challenge in clinics. Understanding the neuroendocrine …
[PDF] u-pec.fr

[PDF][PDF] The Neuropilin-1/PKC Axis Promotes Neuroendocrine Differentiation and Drug Resistance of Prostate Cancer

C Blanc, A Moktefi, A Jolly, P De La Grange, D Gay… - hal.u-pec.fr
Background: Neuroendocrine prostate cancer (NEPC) is a multi-resistant variant of prostate
cancer (PCa) 3 that has become a major challenge in the clinics. Understanding …